% | $
Quotes you view appear here for quick access.

Arcam AB Message Board

  • smcpgrth90 smcpgrth90 Jan 30, 2013 12:57 PM Flag

    AMAVF and OTC risks

    As a younger investor (mid 20's) I feel I can incur more risk with a greater portion of my portfolio, and buying in early december I couldn't be happier with the price movement so far. Yet, I have people (parents, finance professors, etc...) telling me to STAY AWAY from OTC Bulletin Board and Pink Sheets like their the plague and if I'm going the OTC route to only stay in the NNM and Nasdaq Small Cap markets. To say the least, Arcam doesn't seem like a 'fly by night/highway robbery' company like others, some that have "made it" to the big league markets (i.e. REFR). So any advice by seasoned investors on a how younger one can do their due diligence to ensure that their not getting into anything, well, stupid?

    Some lingering questions I still have AMAVF traded on a foreign exchange that is more regulated than the OTC bulletin board market? Someone on here posted 10 institutions, including Goldman Sachs, that collectively own 62% of the shares for AMAVF. Where is the source for this info?

    Arcam's investor portion of their website is in Swedish, is there a place to find English translations of their financial reports?

    Are the # of Arcam EBM machines sold, the approximate dates of the sales, and the amounts they are sold for public knowledge? Someone posted that they sold 5 in a week during December or so, and that the company was profitable selling 4 in 6 months, so 5 in a week will make them exponentially more profitable.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bhuston77 Feb 10, 2013 8:17 PM Flag

      Generally, your parents are right...stay away from the pinks. But when it comes to established foreign issues like this one that trade on major exchanges in the their own countries and that release should be just fine...from a trading standpoint. This would, for me, be the exception to the rule.

    • You are very brave and smart. I plan to buy some amavf. Future is very bright.

      Sentiment: Strong Buy

      • 1 Reply to dou89
      • I appreciate the comment, I like to think this is a bright investment but the liquidity does worry me, especially that it can dip nearly 30% when someone sells. I likely have too much of my portfolio in it, but then again my portfolio is probably orders of magnitude smaller than most investors.

        And I've found answers to all of my questions thanks to the seeking alpha article that another poster kindly referenced. I'm just trying to figure out how to get my money in ARCM on the stockholm exchange, it shouldn't have the liquidity issue we're seeing with AMAVF as it has nearly 4 times the daily volume and the share price is essentially the same...

23.50+0.85(+3.75%)Jun 28 3:50 PMEDT